The genetic and rare diseases information center and its closely inter-related research support activities. POP: 07/29/2019 to 07/28/2020.

Ended Awarded Last action

Contract number
75N95019F00179
Awardee
Awarding agency
Obligated
$5,968,764

Award facts

Opportunity
Contract value 100% obligated
$5,968,764.25 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Time and Materials
Place of performance
Fairfax, VA 22031, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00007 · To administratively DE-obligate unexpended and expiring fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30,… -$66,155
Funding Only Action P00006 -$55,293
Other Administrative Action P00005 $0
Supplemental Agreement for work within scope P00004 $349,612
Supplemental Agreement for work within scope P00003 $0
Exercise an Option P00002 $2,847,481
Supplemental Agreement for work within scope P00001 $123,423
Original award $2,769,696

About this award

The National Institute on Drug Abuse issued a delivery order to ICF Incorporated, L.L.C. on July 29, 2019, with a ceiling value of $5,968,764.25 for the Genetic and Rare Diseases Information Center and its closely inter-related research support activities.

The order was issued under the Professional Services Schedule (PSS) with a performance period from July 29, 2019 to July 28, 2020. Place of performance is Fairfax, VA. Pricing is Time and Materials. The award was administratively de-obligated in preparation for September 30, 2025, closing of fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552(a).

Service Contract Inventory data reflects actual government-invoiced labor: FY2021 recorded 11.1 FTEs and 23,037 contractor hours at a derived rate of $114.40 per hour, with $2.6 million invoiced; FY2020 invoiced $3.7 million. FY2022 reported minimal invoicing of $235 with no subcontractors; ICF self-performed all reported hours.

Quick answers

Who was awarded contract 75N95019F00179?

75N95019F00179 was awarded to ICF Incorporated, L.L.C. by National Institute on Drug Abuse (National Institutes of Health) on July 29, 2019.

How much is contract 75N95019F00179 worth?

The government has obligated $5,968,764 on 75N95019F00179.

Is contract 75N95019F00179 an order under another contract?

Yes. 75N95019F00179 is a delivery order under GS00F010CA, a federal supply schedule, on The Professional Services Schedule (PSS).

Was contract 75N95019F00179 competed?

The extent of competition for 75N95019F00179 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award